If consultants are to stay useful, they need to rethink what they do. The value of consultancies lies chiefly in their ...

The biopharmaceutical company posted adjusted earnings of $0.05 per share for the second quarter, matching analyst estimates. However, revenue came in at $76.53 million, below the consensus estimate ...